4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000063
EVP CLO & General Counsel sold 7,360 shares at $32.83 ($241,629)
- EVP CLO & General Counsel acquired 19,690 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
O'NEIL PATRICK R. · EVP CLO & General Counsel
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-15 | Exercise or conversion : show line 1 in the form | +19,690 | 68,563 | D | ||
| 2025-01-16 | Sale : show line 2 in the form | −7,360 | $32.83 | $241,629 | 61,203 | D |
| Open-market sales · 7,360 sh · avg $32.83 · $241,629 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-15 | Grant or award : show line 3 in the form Performance Restricted Stock Units | +22,000 | 64,801 | D |
| 2025-01-15 | Grant or award : show line 4 in the form Restricted Stock Unit | +33,000 | 80,414 | D |
| 2025-01-15 | Exercise or conversion : show line 5 in the form Restricted Stock Unit | −19,690 | 60,724 | D |
Loading xslF345X05/edgardoc.xml…